Sen. John Boozman Buys UnitedHealth Group Incorporated (NYSE:UNH) Shares

Posted by Geri Gentry on Jul 18th, 2026

Senator John Boozman (Republican-Arkansas) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 13th, the Senator disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on June 4th.

Senator John Boozman also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of abrdn Physical Palladium Shares ETF (NYSEARCA:PALL) on 6/25/2026.
Purchased $1,001 – $15,000 in shares of iShares Expanded Tech-Software Sector ETF (BATS:IGV) on 6/25/2026.
Sold $1,001 – $15,000 in shares of First Trust Global Tactical Commodity Strategy Fund (NASDAQ:FTGC) on 6/25/2026.
Sold $1,001 – $15,000 in shares of (NYSE:TPYP) on 6/25/2026.
Sold $1,001 – $15,000 in shares of iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) on 6/17/2026.
Sold $1,001 – $15,000 in shares of Atmos Energy (NYSE:ATO) on 6/12/2026.
Sold $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 6/4/2026.
Purchased $1,001 – $15,000 in shares of iShares CMBS ETF (NYSEARCA:CMBS) on 5/27/2026.
Purchased $1,001 – $15,000 in shares of iShares MBS ETF (NASDAQ:MBB) on 5/27/2026.
Purchased $1,001 – $15,000 in shares of iShares Agency Bond ETF (NYSEARCA:AGZ) on 5/27/2026.

UnitedHealth Group Stock Performance

Shares of UNH traded up $3.02 on Friday, reaching $426.39. 10,534,342 shares of the stock traded hands, compared to its average volume of 5,513,718. The firm has a market cap of $387.23 billion, a price-to-earnings ratio of 27.44, a P/E/G ratio of 1.58 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $461.62. The stock’s 50-day moving average price is $404.81 and its 200-day moving average price is $342.28. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 19.75 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were given a dividend of $2.32 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 70.09%.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: UnitedHealth beat Q2 estimates on earnings and revenue, driven by improved margins and lower medical costs, and raised its 2026 profit outlook. UnitedHealth shares surge on strong earnings beat and guidance
Positive Sentiment: Morgan Stanley, Oppenheimer, UBS, RBC, and other firms lifted price targets after the results, signaling stronger Street confidence in the stock’s recovery. Analyst price target updates
Positive Sentiment: Management doubled the 2026 share repurchase target to at least $5 billion, which may help support EPS and investor returns. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
Neutral Sentiment: Commentary around the earnings call says Medicare Advantage and Optum are improving, but commercial cost pressures could delay a full margin recovery. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
Negative Sentiment: Some analysts remain cautious, with at least one downgrade noting that the turnaround still faces execution risk despite the stronger quarter. UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Weiss Ratings raised shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 10th. Piper Sandler set a $477.00 target price on UnitedHealth Group in a research report on Thursday. Truist Financial upped their price target on UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research report on Tuesday. Oppenheimer boosted their target price on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Mizuho increased their target price on shares of UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $447.29.

Check Out Our Latest Stock Report on UnitedHealth Group

Institutional Trading of UnitedHealth Group

Several large investors have recently made changes to their positions in the business. Walker Asset Management LLC bought a new stake in UnitedHealth Group during the 2nd quarter worth about $229,000. Ballast Inc. grew its stake in shares of UnitedHealth Group by 11.4% during the second quarter. Ballast Inc. now owns 17,484 shares of the healthcare conglomerate’s stock valued at $7,267,000 after purchasing an additional 1,791 shares during the last quarter. Regent Peak Wealth Advisors LLC raised its position in UnitedHealth Group by 21.3% in the 2nd quarter. Regent Peak Wealth Advisors LLC now owns 1,620 shares of the healthcare conglomerate’s stock worth $673,000 after purchasing an additional 285 shares during the last quarter. Annex Advisory Services LLC boosted its position in UnitedHealth Group by 159.6% in the 2nd quarter. Annex Advisory Services LLC now owns 68,577 shares of the healthcare conglomerate’s stock valued at $28,503,000 after buying an additional 42,157 shares during the last quarter. Finally, Whitener Capital Management Inc. raised its position in shares of UnitedHealth Group by 43.0% during the second quarter. Whitener Capital Management Inc. now owns 3,893 shares of the healthcare conglomerate’s stock worth $1,618,000 after acquiring an additional 1,171 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company’s stock.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas’ U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman’s academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.